Nahoko Nishimoto

Transcription factor RUNX1 promotes survival of acute myeloid leukemia cells

Susumu Goyama, Janet Schibler, Lea Cunningham et al. · Journal of Clinical Investigation · 2013 · 193 citations · Full text

Hematological Malignancy, Transcriptional Regulation, Radiation Oncology +14

AML1/RUNX1 functions as a cytoplasmic attenuator of NF-κB signaling in the repression of myeloid tumors

Masahiro Nakagawa, Munetake Shimabe, Naoko Watanabe‐Okochi et al. · Blood · 2011 · 57 citations · Full text

Decreased incidence of acute graft‐versus‐host disease by continuous infusion of cyclosporine with a higher target blood level

Kumi Oshima, Yoshinobu Kanda, Hideki Nakasone et al. · American Journal of Hematology · 2007 · 55 citations · Full text

T cell acute lymphoblastic leukemia arising from familial platelet disorder

Nahoko Nishimoto, Yoichi Imai, Koki Ueda et al. · International Journal of Hematology · 2010 · 45 citations

Hematological Malignancy, Mixed-phenotype Acute Leukemia, Malignant Blood Disorder +7

Reduced-intensity vs myeloablative conditioning allogeneic hematopoietic SCT for patients aged over 45 years with ALL in remission: a study from the Adult ALL Working Group of the Japan Society for Hematopoietic Cell Transplantation (JSHCT)

Junji Tanaka, Heiwa Kanamori, Satoshi Nishiwaki et al. · Bone Marrow Transplantation · 2013 · 34 citations

Transplantation, Marrow Transplantation, Japan Society +6